Anacor Pharmaceuticals Obtains $50,000,000 New Financing

  • Feed Type
  • Date
    1/6/2009
  • Company Name
    Anacor Pharmaceuticals
  • Mailing Address
    1020 East Meadow Circle Palo Alto, CA 94303-4230
  • Company Description
    Anacor is developing novel pharmaceuticals for a variety of inflammatory and infectious diseases based on its proprietary, small-molecule, boron-based chemistry.
  • Website
    http://www.anacor.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to further develop Anacor’s product pipeline based on its boron chemistry platform.
  • M&A Terms
  • Venture Investor
    GlaxoSmithKline
  • Venture Investor
    Rho Ventures
  • Venture Investor
    Venrock
  • Venture Investor
    Care Capital
  • Venture Investor
    Aberdare Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.